Picard Medical, Inc. (PMI)

NYSEAMERICAN: PMI · USD

$7.24

+0.41 (+6.0%)· Recorded snapshot

Market cap	16.9M
Revenue (ttm)	6.3M
Net income (ttm)	-26.4M
EPS (ttm)	-$17.9
Shares out	2.3M
Volume	41,488

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.3M
Net income (ttm): -26.4M
EPS (ttm): -$17.9
Market cap: 16.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROEn/a

P25 -113.8P50 -46.5P75 -0.9

ROICn/a

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All PMI indicators

Market & fundamental data

Available fields

193

Groups with data

Currency

USD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0002030617
Company name	Picard Medical, Inc.
Country	United States
Country code	US
CUSIP number	71953R207
Earnings date	2026-11-13
Earnings time	bmo
Employees	75
Employees change	-15
Employees growth	-16.67%
Enterprise value	$18.5M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1981
Industry	Medical Devices
IPO date	2025-08-29
Is primary listing	Yes
Is SPAC	No
ISIN number	US71953R2076
Last 10-K release date	2026-03-30
Last earnings date	2026-08-19
Last refreshed	2026-10-28
Last stock split date	2026-08-03
Last stock split type	Reverse
Market cap	$16.9M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$7.24
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	PMI
U.S. state	Arizona
Website	https://www.picardmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-247.02%
EV/Sales	2.78x
FCF / EV yield	-91.76%
FCF yield	-100.6%
Forward EV/Sales	3.02x
Forward P/S	2.75x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/B ratio	8.18x
P/S ratio	2.54x
Price / tangible book value	25.11x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-248.1%
EBITDA margin	-245.37%
Gross margin	18.6%
Operating margin	-248.1%
Pretax margin	-444.16%
Profit per employee	$-352,227
Revenue per employee	$84,000
ROA	-93.62%
ROCE	-910.84%
SBC / revenue	31.35%
Tax / revenue	0.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	1
Net income growth quarters	1
Net income growth years	0
Revenue growth	41.22%
Revenue growth (Q)	38.62%
Revenue growth (QoQ)	156.87%
Revenue growth quarters	5
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-26,000
Depreciation and amortization	$172,000
EBIT	$-15.6M
EBITDA	$-15.5M
EPS	$-17.88
FCF per share	$-6.87
Financing cash flow	$15.7M
Free cash flow	$-16.1M
Free cash flow minus SBC	$-18M
Gross profit	$1.2M
Income taxes	$11,000
Investing cash flow	$-26,000
Net borrowing	$-1.9M
Net cash flow	$-372,000
Net income	$-26.4M
Operating cash flow minus SBC	$-18M
Operating income	$-15.6M
Revenue	$6.3M
Stock-based compensation	$2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-2.44
Book value per share	$0.83
Debt / equity	0.92
Goodwill	$615,000
Interest coverage	-6.24
Long-term assets	$1.6M
Long-term liabilities	$0
Net cash (debt)	$-1.5M
Net cash / market cap	-9.64%
Net debt / equity	0.9
Piotroski F-Score	4
Property, plant and equipment	$495,000
Shareholders' equity	$1.7M
Tangible book value	$636,000
Tangible book value per share	$0.31
Total assets	$9.2M
Total cash	$38,000
Total debt	$1.6M
Total liabilities	$7.5M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.6
Current assets	$7.6M
Current liabilities	$7.5M
Current ratio	1.02
Inventory turnover	0.79
Net working capital	$1.7M
Quick ratio	0.09
Working capital	$141,000
Working capital turnover	-0.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-802.75%
Dividend yield	0%
Shareholder yield	-802.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$16.04
1D price change	6%
1M price change	57.68%
1M total return	57.68%
1W price change	-30.49%
1W total return	-30.49%
1Y price change	-96.93%
1Y return CAGR	-96.94%
1Y total return	-96.93%
20-day SMA	$9.35
200-day SMA	$31.22
3M price change	65.79%
3M total return	65.78%
50-day SMA	$6.98
50-day SMA vs 200-day SMA	50under200
52-week high	$224.59
52-week high date	2025-10-28
52-week low	$2.65
52-week low date	2026-08-21
6M price change	-78.88%
6M total return	-78.88%
All-time high	$684.00
All-time high date	2025-10-23
All-time low	$2.65
All-time low date	2026-08-21
Average true range (ATR)	$2.28
Average volume	599.2K
Beta (1Y)	-1.87
Beta (2Y)	-1.88
Change from 52-week high	-96.78%
Change from 52-week low	173%
Change from all-time high	-98.93%
Change from all-time low	174.7%
Change from open	2.99%
Day's gap	2.93%
Dollar volume	$300,373
High price	$7.26
Low price	$6.94
Monthly RSI	32.7
Open price	$7.03
Position in 52-week range	93.75%
Premarket change	0.15%
Premarket close	$6.83
Premarket price	$6.84
Premarket volume	1.3K
Previous close	$6.83
Price vs 150-day SMA	-54.59%
Price vs 20-day SMA	-22.07%
Price vs 200-day SMA	-76.67%
Price vs 50-day SMA	4.38%
Relative volume	0.07
Return from IPO open	-96.76%
Return from IPO price	70.75%
RSI	47.05
Sharpe ratio	-0.69
Sortino ratio	-1.07
Volume	41.5K
Weekly RSI	38.87
YTD price change	-91.67%
YTD total return	-91.67%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.3M
Float percentage	54.81%
Shares change (QoQ)	24.66%
Shares change (YoY)	802.75%
Shares held by insiders	4.52%
Shares held by institutions	10.38%
Shares outstanding	2.3M
Short % of float	2.94%
Short % of shares	1.61%
Short ratio	0.1 days

Deeper analysis on PMI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PMI report

Is a complete PMI research report available?

No complete published report is available for Picard Medical, Inc. (PMI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Picard Medical, Inc. (PMI)

Price

Financial snapshot

Fair-value bridge

Latest news · PMI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PMI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PMI

Frequently asked questions